ProCE Banner Activity

My Approach to Evidence-Based Treatment of COVID-19 by Disease Severity

Clinical Thought
Here’s why we must target our recommendations to treat patients using agents with strong supporting data.

Released: October 08, 2021

Expiration: October 07, 2022

No longer available for credit.

Share

Faculty

Lynora Saxinger

Lynora Saxinger, MD, FRCPC, CTropMed

Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Lynora Saxinger, MD, FRCPC, CTropMed

Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Lynora Saxinger, MD, FRCPC, CTropMed, has no relevant conflicts of interest to report.